A negative correlation between MAPT expression and resistance to several drugs with various modes of action is detected in pancreatic, uterine, and mainly bone cancer-derived cell lines, whereas predominantly positive correlations were found in cell lines derived from other cancers. The gene discussed is MAPT; the disease is bone cancer.